| Literature DB >> 28765557 |
Lia Danelishvili1, Jessica J J Chinison2,3, Tuan Pham4, Rashmi Gupta2,5, Luiz E Bermudez6,7.
Abstract
Mycobacterium avium subsp. hominissuis is associated with infection of immunocompromised individuals as well as patients with chronic lung disease. M. avium infects macrophages and actively interfere with the host killing machinery such as apoptosis and autophagy. Bacteria alter the normal endosomal trafficking, prevent the maturation of phagosomes and modify many signaling pathways inside of the macrophage by secreting effector molecules into the cytoplasm. To investigate whether M. avium needs to attach to the internal surface of the vacuole membrane before releasing efferent molecules, vacuole membrane proteins were purified and binding to the surface molecules present in intracellular bacteria was evaluated. The voltage-dependent anion channels (VDAC) were identified as components of M. avium vacuoles in macrophages. M. avium mmpL4 proteins were found to bind to VDAC-1 protein. The inactivation of VDAC-1 function either by pharmacological means or siRNA lead to significant decrease of M. avium survival. Although, we could not establish a role of VDAC channels in the transport of known secreted M. avium proteins, we demonstrated that the porin channels are associated with the export of bacterial cell wall lipids outside of vacuole. Suppression of the host phagosomal transport systems and the pathogen transporter may serve as therapeutic targets for infectious diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28765557 PMCID: PMC5539096 DOI: 10.1038/s41598-017-06700-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Magnetically labeled M. avium and isolation of phagosomes. The intact phagosomes of biotin labeled tomato red clone of M. avium were separated from the total THP-1 cells lysate using the streptavidin-coated MACS microbeads as described in Materials and Methods. The labeled phagosomes with the Alexa Fluor 488-conjugated Annexin B (A) Rab5 (B) and Rab7 (C) were visualized for purity under the fluorescent microscopy. Scale bar 5μm. M. avium-containing phagosmes were stained with antibodies against Rab5 or Rab7 for 2 h at a dilution of 1:250 in PBS containing 3% BSA. After washing, phagosomes were probed with FITC-conjugated secondary antibody for 1 h and then processed for fluorescence microscopy. (D) The percentage of co-localized tomato red-labeled M. avium and FITC-labeled Rab5 and Rab7 phagosomal markers was determined by evaluating three hundred bacterial cells and express as the mean ± SD for three separate experiments. Significant differences were observed between Rab5 and Rab7 in their co-localization with the M. avium phagosome. **p < 0.001. The dtTomato M. avium-containing phagosomes stained for Rab5 were analyzed by flow cytometry as well (E). To verify the purity of intracellular M. avium sample and rule out the contaminant host proteins, bacteria isolated from human macrophages at 4 h and 24 h post-infection were incubated with the extraction buffer for 2 h with gentle agitation. The resulting supernatants (F) and the host cell total proteins of infected THP-1 cells (used for isolation of the intracellular M. avium) were visualized on a protein gel with the Coomassie staining (G). The magnetically purified M. avium phagosomes were lysed in 20 mM HEPES supplemented with the 1% Tergitol and protease inhibitor cocktail and visualized on the SDS-PAGE (H).
Phagosomal proteins bound to M. avium surface identified by the mass spectrometric sequencing.
| # | Identified Human Proteins | Accession Number | MW kDa | Peptides | |
|---|---|---|---|---|---|
| 4 h | 24 h | ||||
| 1 | Cluster of Vimentin | VIME_HUMAN [3] | 54 | 26 | 36 |
| 2 | Prelamin-A/C | LMNA_HUMAN (+1) | 74 | 24 | 26 |
| 3 | ATP synthase subunit beta, mitochondrial | ATPB_HUMAN | 57 | 19 | 20 |
| 4 | ATP synthase subunit alpha, mitochondrial | ATPA_HUMAN | 60 | 11 | 12 |
| 5 | Prohibitin | PHB_HUMAN | 30 | 12 | 10 |
| 6 | Cluster of ADP/ATP translocase 2 | ADT2_HUMAN | 33 | 7 | 12 |
| 7 | Heterogeneous nuclear ribonucleoprotein A3 | ROA3_HUMAN | 40 | 11 | 8 |
| 8 | Cluster of Histone H2A (Fragment) | H0YFX9_HUMAN [12] | 10 | 10 | 10 |
| 9 | U5 small nuclear ribonucleoprotein 200 kDa helicase | U520_HUMAN | 245 | 11 | 7 |
| 10 | Annexin A5 | ANXA5_HUMAN (+1) | 36 | 8 | 9 |
| 11 | ATP-dependent RNA helicase A | DHX9_HUMAN | 141 | 6 | 8 |
| 12 | Splicing factor 3B subunit 3 | SF3B3_HUMAN | 136 | 8 | 6 |
|
|
|
|
|
|
|
| 14 | 60 S acidic ribosomal protein P2 | RLA2_HUMAN | 12 | 7 | 8 |
| 15 | Cluster of Histone H2B | B4DR52_HUMAN [11] | 18 | 6 | 6 |
| 16 | Heterogeneous nuclear ribonucleoprotein M | HNRPM_HUMAN | 78 | 7 | 3 |
| 17 | Histone H4 | H4_HUMAN | 11 | 7 | 6 |
| 18 | Prohibitin-2 | J3KPX7_HUMAN (+1) | 33 | 7 | 4 |
| 19 | 60 S ribosomal protein L4 | RL4_HUMAN | 48 | 5 | 7 |
| 20 | Heterogeneous nuclear ribonucleoproteins A2/B1 | ROA2_HUMAN | 37 | 5 | 6 |
| 21 | Splicing factor 3B subunit 1 | SF3B1_HUMAN | 146 | 6 | 4 |
| 22 | Cluster of Heterogeneous nuclear ribonucleoprotein L | HNRPL_HUMAN [2] | 64 | 6 | 5 |
| 23 | Pre-mRNA-processing-splicing factor 8 | PRP8_HUMAN | 274 | 7 | 3 |
| 24 | Heterogeneous nuclear ribonucleoprotein A1 | F8VZ49_HUMAN (+2) | 26 | 5 | 4 |
|
|
|
|
|
|
|
| 26 | 116 kDa U5 small nuclear ribonucleoprotein | K7EJ81_HUMAN (+1) | 108 | 5 | 4 |
| 27 | 60 S ribosomal protein L9 (Fragment) | D6RAN4_HUMAN (+2) | 21 | 6 | 3 |
| 28 | Cluster of 60 S acidic ribosomal protein P0 (Fragment) | F8VU65_HUMAN [3] | 27 | 4 | 6 |
| 29 | rRNA 2’-O-methyltransferase fibrillarin | FBRL_HUMAN | 34 | 5 | 2 |
| 30 | 60 S ribosomal protein L10a | RL10A_HUMAN | 25 | 5 | 5 |
|
|
|
|
|
|
|
| 32 | Cluster of Heterogeneous nuclear ribonucleoprotein H2 | HNRH2_HUMAN [2] | 49 | 3 | 4 |
| 33 | Polypyrimidine tract-binding protein 1 | PTBP1_HUMAN | 57 | 5 | 3 |
M. avium proteins identified in phagosomal protein fraction bound to bacterial surface.
| # | Identified | Accession | MW kDa | Peptides | |
|---|---|---|---|---|---|
| 4 h | 24 h | ||||
|
|
|
|
|
|
|
| 2 | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase, ispD | A0QAB3 | 23 | 2 | 0 |
|
|
|
|
|
|
|
| 4 | Transcriptional regulator, TetR family protein, MAV_2167 | A0QEN8 | 20 | 0 | 2 |
| 5 | 2-hydroxy-6-ketonona-2,4-dienedioic acid hydrolase, MAV_2517 | A0QFM11 | 32 | 0 | 2 |
| 6 | Dehydrogenase, MAV_3890 | A0QJG41 | 56 | 0 | 2 |
| 7 | Acyl-CoA synthase, MAV_0030 | A0Q8U2 | 54 | 2 | 0 |
Figure 2Suppression of M. avium growth in macrophages during VDAC inhibition. (A) THP-1 cells were pretreated with 5 μM CsA and then infected with M. avium up to 3 day; cultures were harvested at indicated time points and bacterial number were determent by CFU counts. Results represent mean ± standard error of three independent experiments. **p < 0.01, the significance of differences between CsA treated and control groups at the corresponding time points. (B) Macrophages were pretreated and cultured in DIDS or control medium. Bacterial number was determined at 4 h, and 1, 2, and 3 days post-infection by plating cell lysates on 7H10 agar plates. The difference in DIDS-treated THP-1 cultures compared with untreated cells was statistically significant at day 1, 2 and 3 (P < 0.01, t test). Data are representative of three experiments. (C) In vitro growth of M. avium in aerated 7H9 medium containing DVAC inhibitors at concentrations used for tissue culture infection studies. (D) THP-1 cells (approximately 105/ml) were seeded and differentiated into macrophages with PMA in 6-well plate. After 24 h, cells were replenished with new medium and allowed to rest additional 48 h. Macrophage monolayers were washed with siRNA transfection medium and replaced with either the VDAC-1 siRNA transfection reagent or the scrabbled sequences of negative control siRNA 24 hours prior M. avium infection. Briefly, cells were lysed in CelLytic™ M lysis buffer supplemented with protease inhibitor cocktail (Sigma) and pre-cleared samples were separated on 12% Tris–HCl gels. Membranes were blocked with 3% BSA for 1 h and incubated with VDAC-1 primary antibody at a 1:250 dilution for 2 h. After, membrane was probed with the corresponding IRDye® secondary antibody (Li-Cor Biosciences, Inc) at a dilution of 1:5,000 for 30 min. THP-1 cells transfected with VDAC-1 siRNA for 72 h demonstrates efficient and specific silencing of VDAC-1 quantified via semi-quantitative western blot on the Odyssey Imager (Li-Cor). The photon emission means were recorded for each band to quantify the signal intensity. Beta-actin was used as a loading control. (E) Intracellular CFU decrease at several times of post-infection of transfected THP-1 cells with VDAC-1 siRNA or siRNA control and infected with M. avium. Data are means ± SD of three independent experiments. **p < 0.01 and *p < 0.05, the significance of differences between VDAC-1 knock down and siRNA control or M. avium infection groups.
Figure 3In vitro protein-protein interaction between VDAC-1 and M. avium effectors. The open reading frame of VDAC-1 cDNA encoding a 283 amino acid protein was amplified from the human sequence-verified Clone ID: 6023095 (Dharmacon), which was isolated from the NIH_MGC library. The yeast two-hybrid interaction of VDAC-1 with the bacterial target proteins MAV_1177 (1), MAV_2921 (2), MAV_2941 (3) and CipA (4) showed a negative or false positive interaction. The screening of mmpL4 lipoproteins MAV_0084 (5) and MAV_4996 (6) as well as ATP synthase alpha (7) and beta (8) subunits established positive interaction with VDAC-1. The known interaction between pGBKT7-53 and pGADT7-T served as a positive control (+), whereas pGBKT7-lam and pGADT7-T were used as a control for a negative interaction (−).
M. avium proteins bound to VDAC-1 identified by pull-down assay.
| # | Identified Proteins | Accession | MW kDa | Peptides |
|---|---|---|---|---|
| 1 | ATP synthase subunit alpha, MAV_1525 | ABK67333 | 59 | 2 |
| 2 | ATP synthase subunit beta, MAV_1527 | ABK66662 | 53 | 6 |
Figure 4The co-localization of VDAC-1 on phagosomes of M. avium expressing mmpL4 protein. Representative images of constitutively expressing RFP (A) and RFP:mmpL4 (B) proteins in M. avium show subcellular co-localization of VDAC-1 on bacterial vacuoles. The arrows highlight specific regions of interest visualizing the overlapping yellow pixel clusters (co-localization). Images contain uninfected control cells as well. All images were obtained using 100x oil objective of a fluorescent microscope (Leica). Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). Two images are included for each experimental group. Bar = 10 μm.
Figure 5M. avium cell wall lipid release inside of macrophages. (A) THP-1 cells with or without DIDS treatment were infected with Texas Red hydrazyde-labeled M. avium with MOI of 25:1 for 24 h and analyzed by fluorescent microscopy. While significant release of fluorescent label from bacterial phagosomes are observed in wells without DIDS treatment, the export of bacterial cell wall components into the cytosol of macrophages are substantially reduced as observed on micrographs obtained from infected THP-1 cells during VDAC inhibition. Two images are included for each experimental group. Scale bar 10μm. (B) The percentage of the host macrophages permeated the red fluorescence released from the Texas Red hydrazyde-labeled M. avium. Results represent means ± standard error of three independent experiments. *, p < 0.001, the significance of differences between M. avium infected THP1 cells with and without DIDS treatment. (C) M. avium infected THP-1 macrophages with DIDS (blue trace) or without DIDS (red trace) treatment were analyze by flow cytometry to discern lipid transport as described in the materials and methods. The host cells without infection are shaded grey. (D) To visualize and demonstrate the colocalization of Rab5 with the Texas Red hydrazide stained M. avium directly in THP-1 infected cells without DIDS treatment was technically impossible, due to the massive release of lipids within the host cells. Thus, the percentage of M. avium co-localization with Rab5 phagosomal marker was determined by evaluating three hundred M. avium-containing phagosmes, which were isolated from THP-1 cells with and without DIDS treatment at 24 h post-infection as described in materials and methods. Results represent means ± standard error of two independent experiments.